EP2421517A4 - Controlled release dispensing device - Google Patents

Controlled release dispensing device

Info

Publication number: EP2421517A4
Authority: EP; European Patent Office
Prior art keywords: controlled release; dispensing device; release dispensing; controlled; release
Prior art date: 2009-04-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP10767428.5A

Other languages

German (de)

French (fr)

Other versions

EP2421517A2 (en

Inventor

Libin Barry

Jeffrey M Liebmann

Weiliam Chen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SUSTAINED NANO SYSTEMS LLC

Original Assignee

SUSTAINED NANO SYSTEMS LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-23

Filing date

2010-04-21

Publication date

2013-08-07

2009-04-23 Priority claimed from US12/386,853 external-priority patent/US8071119B2/en

2009-11-25 Priority claimed from US12/592,536 external-priority patent/US20100173000A1/en

2010-04-21 Application filed by SUSTAINED NANO SYSTEMS LLC filed Critical SUSTAINED NANO SYSTEMS LLC

2012-02-29 Publication of EP2421517A2 publication Critical patent/EP2421517A2/en

2013-08-07 Publication of EP2421517A4 publication Critical patent/EP2421517A4/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP10767428.5A 2009-04-23 2010-04-21 Controlled release dispensing device Ceased EP2421517A4 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US21445209P	2009-04-23	2009-04-23
US12/386,853 US8071119B2 (en)	2007-05-14	2009-04-23	Controlled release implantable dispensing device and method
US12/592,536 US20100173000A1 (en)	2007-05-14	2009-11-25	Controlled release implantable dispensing device and method
PCT/US2010/001191 WO2010123563A2 (en)	2009-04-23	2010-04-21	Controlled release dispensing device

Publications (2)

Publication Number	Publication Date
EP2421517A2 EP2421517A2 (en)	2012-02-29
EP2421517A4 true EP2421517A4 (en)	2013-08-07

Family

ID=43011665

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP10767428.5A Ceased EP2421517A4 (en)	2009-04-23	2010-04-21	Controlled release dispensing device

Country Status (4)

Country	Link
EP (1)	EP2421517A4 (en)
JP (2)	JP2012524779A (en)
CA (1)	CA2759807C (en)
WO (1)	WO2010123563A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013020094A2 (en) *	2011-08-03	2013-02-07	Avant Garde Therapeutics Inc.	Novel hemostatic patch and uses thereof
JP7357367B2 (en) *	2017-07-11	2023-10-06	サステインドナノシステムズエルエルシー	Radiation sterilization of ultracompacted polymer dosage forms
AU2018300080B2 (en)	2017-07-11	2024-09-19	Sustained Nano Systems Llc	Hypercompressed pharmaceutical formulations
BR102020025389A2 (en) *	2020-12-11	2022-06-21	Edson Luiz Peracchi	Long-term resorbable subcutaneous implant with sustained release of pre-concentrated, polymer-concentrated pharmacologically active substance for the treatment of nicotine addiction and process

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020111603A1 (en) *	1996-12-02	2002-08-15	Societe De Conseils De Recherches Et D'application	Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5899411A (en) *	1981-12-05	1983-06-13	Shoichiro Ozaki	Carcinostatic agent
US4478818A (en) *	1982-12-27	1984-10-23	Alza Corporation	Ocular preparation housing steroid in two different therapeutic forms
CH679207A5 (en) *	1989-07-28	1992-01-15	Debiopharm Sa
FR2756493B1 (en) *	1996-12-02	2001-04-13	Delab	DEVICE FOR LOCAL ADMINISTRATION OF SOLID OR SEMI-SOLID FORMULATIONS
BR9908936A (en) *	1998-03-20	2005-10-25	Takeda Chemical Industries Ltd	Processes for producing a sustained release preparation, and for producing a physiologically active polypeptide powder, sustained release preparation, physiologically active polypeptide powder, and, uses of physiologically active polypeptide powder, and a water-miscible organic solvent and / or a volatile salt
DE19856432A1 (en) *	1998-12-08	2000-06-15	Basf Ag	Nanoparticulate core-shell systems and their use in pharmaceutical and cosmetic preparations
DE10224170A1 (en) *	2002-05-31	2003-12-11	Desitin Arzneimittel Gmbh	Retarded release pharmaceutical composition, obtained without use of organic solvents or water by densifying mixture of active agent and retarding polymer in heated rollers
JP4475891B2 (en) *	2003-06-20	2010-06-09	ホソカワミクロン株式会社	Method for producing transpulmonary preparation
WO2006017852A2 (en) *	2004-08-12	2006-02-16	Quest Pharmaceutical Services	Pharmaceutical compositions for controlled release delivery of biologically active compounds
FR2880273B1 (en) *	2004-12-30	2007-03-30	Ceva Sante Animale Sa	PROCESS FOR SEPARATING A SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE AND CONTROLLED AT HIGH PRESSURES
EP2160184B1 (en) *	2007-05-14	2018-03-07	Sustained Nano Systems Llc	Hypercompressed particles for controlled release of ophthalmic medications

2010
- 2010-04-21 WO PCT/US2010/001191 patent/WO2010123563A2/en active Application Filing
- 2010-04-21 EP EP10767428.5A patent/EP2421517A4/en not_active Ceased
- 2010-04-21 JP JP2012507215A patent/JP2012524779A/en active Pending
- 2010-04-21 CA CA2759807A patent/CA2759807C/en active Active
2015
- 2015-09-07 JP JP2015175545A patent/JP6250005B2/en active Active

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020111603A1 (en) *	1996-12-02	2002-08-15	Societe De Conseils De Recherches Et D'application	Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process

Also Published As

Publication number	Publication date
JP2016028066A (en)	2016-02-25
JP2012524779A (en)	2012-10-18
WO2010123563A3 (en)	2011-03-17
WO2010123563A2 (en)	2010-10-28
CA2759807A1 (en)	2010-10-28
CA2759807C (en)	2018-03-20
EP2421517A2 (en)	2012-02-29
JP6250005B2 (en)	2017-12-20

Publication	Publication Date	Title
HK1203163A1 (en)	2015-10-23	Medicament dispensing device
EP2427379A4 (en)	2016-03-23	Dispensing apparatus
GB0909818D0 (en)	2009-07-22	Device
EP2413443A4 (en)	2012-12-05	Ion-generation device
GB0905352D0 (en)	2009-05-13	Device
GB0915541D0 (en)	2009-10-07	Improved dispensing device
EP2441976A4 (en)	2016-03-23	Vibrationproof device
EP2409882A4 (en)	2012-07-25	Seatbelt device
EP2295987A4 (en)	2013-03-06	Dispensing device
ZA201105956B (en)	2012-10-31	Ejection device
ZA201105243B (en)	2012-03-28	Dispensing device
EP2421517A4 (en)	2013-08-07	Controlled release dispensing device
EP2476591A4 (en)	2013-03-06	Seatbelt device
GB0909368D0 (en)	2009-07-15	Device
GB0908083D0 (en)	2009-06-24	Anti-pecking device
GB2474673B (en)	2014-02-19	Dispensing device
GB2474424B (en)	2015-03-18	Controlled dispenser
GB2473070B (en)	2011-09-28	Dispensing apparatus
GB0900160D0 (en)	2009-02-11	Device
IL214193A0 (en)	2011-08-31	Doseg dispensing device
GB2469664B (en)	2014-02-19	Dispensing apparatus
GB0807038D0 (en)	2008-05-21	Dispensing device
GB0820080D0 (en)	2008-12-10	Dispensing device
IL216966A0 (en)	2012-02-29	Local therapeutic release device
GB0810122D0 (en)	2008-07-09	Dispenser device

Legal Events

Date	Code	Title	Description
2012-01-27	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2012-02-29	17P	Request for examination filed	Effective date: 20111028
2012-02-29	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
2012-08-15	DAX	Request for extension of the european patent (deleted)
2013-08-07	A4	Supplementary search report drawn up and despatched	Effective date: 20130708
2013-08-07	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/20 20060101ALI20130702BHEP Ipc: A61K 9/52 20060101AFI20130702BHEP Ipc: A61K 9/51 20060101ALI20130702BHEP Ipc: A61K 9/00 20060101ALI20130702BHEP Ipc: A61K 9/50 20060101ALI20130702BHEP Ipc: A61M 35/00 20060101ALI20130702BHEP Ipc: A61K 9/16 20060101ALI20130702BHEP Ipc: A61K 47/30 20060101ALI20130702BHEP
2014-04-23	17Q	First examination report despatched	Effective date: 20140325
2019-03-08	REG	Reference to a national code	Ref country code: DE Ref legal event code: R003
2019-06-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2019-07-31	18R	Application refused	Effective date: 20190308